Drugs / CD34+ hematopoietic stem cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT01740869 | Nov 2012 → Nov 2016 | autism | Hospital Universitario Dr. Jose E. Gonzalez | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD34+ hematopoietic stem cells | “Bone marrow will be harvested, processed to isolate CD34+ hematopoietic stem cells and reduce red blood cells.” NCT01740869 ↗ |
| Route | Intrathecal | “An inoculum of 5-10 mL will then be infused intrathecally into the cerebrospinal fluid.” NCT01740869 ↗ |